BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)

NCT04839471 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National Health Research Institutes, Taiwan

Collaborators